CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+29.24%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$9.46B
AUM Growth
+$433M
(+4.8%)
Cap. Flow
-$87.8M
Cap. Flow
% of AUM
-0.93%
Top 10 Holdings %
Top 10 Hldgs %
21.63%
Holding
907
New
103
Increased
255
Reduced
393
Closed
103
Top Buys
| 1 |
BPMC
Blueprint Medicines
BPMC
|
$59.9M |
| 2 |
Merck
MRK
|
$49.9M |
| 3 |
Danaher
DHR
|
$49.5M |
| 4 |
JD.com
JD
|
$44.8M |
| 5 |
Thermo Fisher Scientific
TMO
|
$40.8M |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
$114M |
| 2 |
Alibaba
BABA
|
$102M |
| 3 |
Salesforce
CRM
|
$58.9M |
| 4 |
Bristol-Myers Squibb
BMY
|
$58.4M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$52M |
Sector Composition
| 1 | Healthcare | 34.68% |
| 2 | Technology | 20.98% |
| 3 | Consumer Discretionary | 8.92% |
| 4 | Financials | 8.6% |
| 5 | Communication Services | 7.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Booking.com
BKNG
$178B
| $9.08M | 0.1% |
5,704
-3,061
| -35% | -$4.87M |
|
227
ResMed
RMD
$40.6B
| $9M | 0.1% |
46,885
+35,351
| +306% | +$6.79M |
|
228
Hershey
HSY
$37.6B
| $8.92M | 0.09% |
68,844
+43,404
| +171% | +$5.63M |
|
229
DuPont de Nemours
DD
$32.6B
| $8.92M | 0.09% |
167,790
-55,418
| -25% | -$2.94M |
|
230
Colgate-Palmolive
CL
$68.8B
| $8.89M | 0.09% |
121,296
-35,946
| -23% | -$2.63M |
|
|
EIDX
231
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $8.85M | 0.09% |
185,721
+13,966
| +8% | +$666K |
|
232
Goldman Sachs
GS
$223B
| $8.82M | 0.09% |
44,632
+39,514
| +772% | +$7.81M |
|
|
CLVS
233
DELISTED
Clovis Oncology, Inc.
CLVS
| $8.77M | 0.09% |
1,298,450
+298,535
| +30% | +$2.02M |
|
|
AERI
234
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $8.74M | 0.09% |
591,800
-78,000
| -12% | -$1.15M |
|
235
Tetra Tech
TTEK
$9.48B
| $8.7M | 0.09% |
493,060
+241,195
| +96% | +$4.26M |
|
236
Zions Bancorporation
ZION
$8.34B
| $8.68M | 0.09% |
255,203
-158,535
| -38% | -$5.39M |
|
237
FibroGen
FGEN
$48.9M
| $8.67M | 0.09% |
8,556
-700
| -8% | -$709K |
|
238
SolarEdge
SEDG
$2.04B
| $8.49M | 0.09% |
61,148
+15,338
| +33% | +$2.13M |
|
|
MOR
239
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $8.45M | 0.09% |
266,750
+159,044
| +148% | +$5.04M |
|
240
Bilibili
BILI
$9.25B
| $8.41M | 0.09% |
+181,500
| New | +$8.41M |
|
241
Idexx Laboratories
IDXX
$51.4B
| $8.33M | 0.09% |
25,214
+18,061
| +252% | +$5.96M |
|
242
Mondelez International
MDLZ
$79.9B
| $8.23M | 0.09% |
160,850
-136,111
| -46% | -$6.96M |
|
|
KSU
243
DELISTED
Kansas City Southern
KSU
| $8.16M | 0.09% |
54,647
+45,672
| +509% | +$6.82M |
|
244
Kinder Morgan
KMI
$59.1B
| $8.16M | 0.09% |
537,712
-213,261
| -28% | -$3.24M |
|
245
Stryker
SYK
$150B
| $8.08M | 0.09% |
44,860
-11,439
| -20% | -$2.06M |
|
246
Insmed
INSM
$30.7B
| $8.04M | 0.08% |
+292,000
| New | +$8.04M |
|
|
ALLK
247
DELISTED
Allakos
ALLK
| $8.04M | 0.08% |
111,872
+61,872
| +124% | +$4.45M |
|
248
AutoZone
AZO
$70.6B
| $7.95M | 0.08% |
7,045
+4,648
| +194% | +$5.24M |
|
249
Power Integrations
POWI
$2.52B
| $7.93M | 0.08% |
134,274
+56,396
| +72% | +$3.33M |
|
250
Oneok
OKE
$45.7B
| $7.9M | 0.08% |
132,714
-679
| -0.5% | -$40.4K |
|